相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation
Samhar I. Al-Akash et al.
PEDIATRIC NEPHROLOGY (2011)
Epidemiological Approach to Identifying Genetic Predispositions for Atypical Hemolytic Uremic Syndrome
Maren Sullivan et al.
ANNALS OF HUMAN GENETICS (2010)
Mendelian genetics of rare-and not so rare-cancers
Charis Eng
YEAR IN HUMAN AND MEDICAL GENETICS: NEW TRENDS IN MENDELIAN GENETICS (2010)
Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
Iain Moore et al.
BLOOD (2010)
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
Marina Noris et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Atypical hemolytic uremic syndrome
David Kavanagh et al.
CURRENT OPINION IN HEMATOLOGY (2010)
Thrombotic microangiopathies: new insights and new challenges
Peter F. Zipfel et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Pathogenicity of DNA Variants and Double Mutations in Multiple Endocrine Neoplasia Type 2 and Von Hippel-Lindau Syndrome
Zoran Erlic et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
New Treatment Options for Atypical Hemolytic Uremic Syndrome with the Complement Inhibitor Eculizumab
Oezlem Koese et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome
Mieke Delvaeye et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Complement regulatory genes and hemolytic uremic syndromes
David Kavanagh et al.
ANNUAL REVIEW OF MEDICINE (2008)
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
Veronique Fremeaux-Bacchi et al.
BLOOD (2008)
Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting:: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
D. Gareth Evans et al.
BMC CANCER (2008)
Genetics of HUS:: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
Jessica Caprioli et al.
BLOOD (2006)
Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome
Veronique Fremeaux-Bacchi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome
MA Dragon-Durey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
V Fremeaux-Bacchi et al.
JOURNAL OF MEDICAL GENETICS (2004)
Familial haemolytic uraemic syndrome and an MCP mutation
M Noris et al.
LANCET (2003)
Haemolytic uraemic syndrome and mutations of the factor H gene:: a registry-based study of German speaking countries
HPH Neumann et al.
JOURNAL OF MEDICAL GENETICS (2003)
Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome
P Sánchez-Corral et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): The new thinking
JX Liu et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2001)
Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition
A Richards et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)